Volume 4, Issue 2, Pages (August 2006)

Slides:



Advertisements
Similar presentations
Volume 10, Issue 4, Pages (October 2009)
Advertisements

Does Hypothalamic Inflammation Cause Obesity?
More Than Satiety: Central Serotonin Signaling and Glucose Homeostasis
Volume 7, Issue 4, Pages (April 2008)
Volume 138, Issue 7, Pages e1 (June 2010)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 11, Issue 4, Pages (April 2010)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 155, Issue 2, Pages (August 2018)
Volume 6, Issue 3, Pages (September 2007)
Volume 18, Issue 2, Pages (August 2013)
Volume 12, Issue 5, Pages (November 2010)
Volume 23, Issue 1, Pages (January 2016)
Volume 14, Issue 4, Pages (October 2011)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 4, Issue 3, Pages (September 2006)
Volume 12, Issue 1, Pages (July 2010)
Volume 59, Issue 6, Pages (September 2008)
Volume 14, Issue 6, Pages (December 2011)
Volume 3, Issue 3, Pages (March 2006)
Volume 19, Issue 1, Pages (January 2014)
Volume 42, Issue 6, Pages (June 2004)
Volume 16, Issue 7, Pages (August 2016)
Protection against High-Fat-Diet-Induced Obesity in MDM2C305F Mice Due to Reduced p53 Activity and Enhanced Energy Expenditure  Shijie Liu, Tae-Hyung.
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 13, Issue 4, Pages (April 2011)
Critical Role for Hypothalamic mTOR Activity in Energy Balance
Volume 16, Issue 4, Pages (October 2012)
Volume 3, Issue 2, Pages (February 2006)
Volume 13, Issue 2, Pages (February 2011)
Volume 17, Issue 4, Pages (April 2013)
Volume 10, Issue 5, Pages (November 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 9, Issue 1, Pages (January 2009)
Volume 9, Issue 4, Pages (November 2014)
Volume 1, Issue 4, Pages (April 2005)
Volume 24, Issue 8, Pages e7 (August 2018)
Syntaxin 4 Overexpression Ameliorates Effects of Aging and High-Fat Diet on Glucose Control and Extends Lifespan  Eunjin Oh, Richard A. Miller, Debbie C.
Volume 15, Issue 5, Pages (May 2012)
Volume 49, Issue 2, Pages (January 2006)
Volume 6, Issue 3, Pages (September 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 10, Issue 5, Pages (November 2009)
Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis  Sarah H. Bates, Rohit N. Kulkarni, Matthew.
Volume 9, Issue 6, Pages (June 2009)
Volume 8, Issue 5, Pages (November 2008)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Volume 159, Issue 2, Pages (October 2014)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Circadian Dysfunction Induces Leptin Resistance in Mice
Volume 14, Issue 2, Pages (August 2011)
Volume 5, Issue 6, Pages (June 2007)
Volume 7, Issue 3, Pages (March 2008)
Volume 22, Issue 6, Pages (December 2015)
Volume 7, Issue 6, Pages (June 2008)
Volume 9, Issue 6, Pages (June 2009)
PPARγ in Vagal Neurons Regulates High-Fat Diet Induced Thermogenesis
Volume 20, Issue 4, Pages (October 2014)
Lipin, a lipodystrophy and obesity gene
Volume 5, Issue 5, Pages (May 2007)
Volume 4, Issue 5, Pages (November 2006)
AgRP in energy balance: Will the real AgRP please stand up?
Volume 6, Issue 5, Pages (November 2007)
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Volume 60, Issue 4, Pages (November 2008)
Volume 26, Issue 2, Pages e3 (January 2019)
Volume 5, Issue 3, Pages (March 2007)
Volume 16, Issue 3, Pages (September 2012)
Volume 6, Issue 6, Pages (December 2007)
Presentation transcript:

Volume 4, Issue 2, Pages 123-132 (August 2006) Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells  Paul Kievit, Jane K. Howard, Michael K. Badman, Nina Balthasar, Roberto Coppari, Hiroyuki Mori, Charlotte E. Lee, Joel K. Elmquist, Akihiko Yoshimura, Jeffrey S. Flier  Cell Metabolism  Volume 4, Issue 2, Pages 123-132 (August 2006) DOI: 10.1016/j.cmet.2006.06.010 Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 1 Deletion of Socs-3 from POMC-expressing neurons A and B) Double in situ hybridization for POMC (digoxigenin labeled, brown stain) and Socs-3 (35S labeled, silver grains) in leptin treated Socs-3lox/lox (Socs-3 WT) (A) and Socs-3lox/lox; POMC-Cre (Socs-3 POMC-Cre) mice (B) (n = 3). C) Percentage of POMC labeled neurons that were positive for Socs-3. Neurons were counted positive when the silver grain content exceeded 5× over background. ∗p < 0.001 by Student's t test. Cell Metabolism 2006 4, 123-132DOI: (10.1016/j.cmet.2006.06.010) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 2 Socs-3lox/lox; POMC-Cre mice are more sensitive to exogenous leptin A) The change in body weight over 14 days in response to implantation of a osmotic minipump delivering 0.3 μg leptin per hour in Socs-3lox/lox (Socs-3 WT) (n = 7) and Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre) (n = 6). B) Total food intake (g) over 14 days. C) Final leptin levels (ng/ml). D) Linear regression of the body weight loss correlated to terminal leptin levels. E) Hypothalamic expression of POMC, NPY, and AgRP, relative to total 18S RNA content. ∗p < 0.05 by Student's t test. Cell Metabolism 2006 4, 123-132DOI: (10.1016/j.cmet.2006.06.010) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 3 Improved glucose tolerance in Socs-3lox/lox; POMC-Cre mice A) Body weight curves of Socs-3lox/lox (Socs-3 WT) (n = 9) and Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre) (n = 9). B) Total food intake over 11 weeks and terminal blood glucose levels (26 weeks of age). C) Blood glucose (fed state) levels at the end of the study. D) Glucose tolerance test at 23 weeks of age (1.5 mg glucose/g body weight). E) Insulin tolerance test at 22 weeks of age (1 mU Humulin R/g body weight). ∗p < 0.05 by Student's t test. Cell Metabolism 2006 4, 123-132DOI: (10.1016/j.cmet.2006.06.010) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 4 Socs-3lox/lox; POMC-Cre mice have attenuated weight increase on a high-fat diet A) Body weight curves of Socs-3lox/lox (Socs-3 WT) (n = 8) and Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre) (n = 10) on a high-fat, high-carbohydrate diet. Diet started at 8 weeks of age. ∗p < 0.05 between genotypes for given week. Body weights at week 19 are 39.1 ± 2.0 and 42.8 ± 1.6. B) Total food intake over 11 weeks on a HFD. C) Leptin levels in either the fed or fasted state. D) Oxygen consumption averaged over a 24 hr period. E) Respiratory exchange ratio (VO2/VCO2) averaged over a 24 hr period. F) Activity averaged over a 24 hr period. G) Average heat generated over a 24 hr period. ∗p < 0.001 by Student's t test. Cell Metabolism 2006 4, 123-132DOI: (10.1016/j.cmet.2006.06.010) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 5 Socs-3lox/lox; POMC-Cre mice have an improved glucose homeostasis on HFD A) Glucose tolerance test at 23 weeks of age (1.5 mg glucose/g body weight) in Socs-3lox/lox (Socs-3 WT) (n = 8) and Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre) (n = 10). B) Insulin tolerance test at 22 weeks of age (1 mU Humulin R/g body weight). C) Terminal insulin levels of fed mice. D) Correlation between fasted insulin levels and body weights between the groups. E) Terminal blood glucose levels in fed mice. ∗p < 0.05 by Student's t test. Cell Metabolism 2006 4, 123-132DOI: (10.1016/j.cmet.2006.06.010) Copyright © 2006 Elsevier Inc. Terms and Conditions

Figure 6 Socs-3lox/lox; POMC-Cre mice are protected from development of enlarged liver and have reduced levels of SCD-1 A) Liver weight expressed as a percentage of body weight in Socs-3lox/lox (Socs-3 WT) (n = 9) and Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre) (n = 9) on regular-chow diet or Socs-3lox/lox (Socs-3 WT) (n = 8) and Socs-3lox/lox; POMC-Cre mice (Socs-3 POMC-Cre) (n = 10) on a HFD. B–F) Gene expression analysis using real-time PCR of SCD-1 (B), PGC-1a (C), SREBP-1 (D), PEPCK (E), and Socs-3 (F). ∗p < 0.05 by Student's t test. Cell Metabolism 2006 4, 123-132DOI: (10.1016/j.cmet.2006.06.010) Copyright © 2006 Elsevier Inc. Terms and Conditions